Using real world evidence to generate cost-effectiveness analysis of fibrinolytic therapy in patients with ST-segment elevation myocardial infarction in Thailand

BACKGROUND: Due to limited access to primary percutaneous coronary intervention for the management of ST-segment elevation myocardial infarction (STEMI) in low-to-middle-income countries (LMICs), fibrinolysis serves as a vital alternative reperfusion therapy. Among fibrinolytic agents, the cost-effe...

Descripción completa

Detalles Bibliográficos
Autores principales: Trerayapiwat, Krittimeth, Jinatongthai, Peerawat, Vathesatogkit, Prin, Sritara, Piyamitr, Paengsai, Ninutcha, Dilokthornsakul, Piyameth, Nathisuwan, Surakit, Le, Lan My, Chaiyakunapruk, Nathorn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9250039/
https://www.ncbi.nlm.nih.gov/pubmed/35789828
http://dx.doi.org/10.1016/j.lanwpc.2022.100503

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9250039/
https://www.ncbi.nlm.nih.gov/pubmed/35789828
http://dx.doi.org/10.1016/j.lanwpc.2022.100503

Ejemplares similares